Logo
Title
Regulatory Rapporteur January 2022
Summary
Advances in Clinical Trials: Innovative approaches to promoting diversity and patient access via technology Plus: • Article: A regulatory lens on an industry imperative: Diversity in clinical research • Interview: Facilitating the use of information to improve global health • Meeting Report: The EMA’s Veterinary Big Data Stakeholder Forum (Part 1)
DocumentAccess
Regulatory Rapporteur January 2022MEMBERS
Nonclinical immunogenicity evaluation in toxicology studies of biopharmaceuticalsMEMBERS
Substance-based medical devices: Regulatory challenges and prospectsMEMBERS
Clinical Trial Information System: overview, opportunities and challengesMEMBERS
Facilitating the use of information to improve global healthMEMBERS
The EMA’s Veterinary Big Data Stakeholder Forum (Part 1)MEMBERS
Requirements for the good distribution practice of medicinal productsMEMBERS
On the path to adoption of decentralised clinical trialsMEMBERS
What does 2022 have in store for clinical trials? PUBLIC
A regulatory lens on an industry imperative: Diversity in clinical research PUBLIC